Product Information
TEMAZEPAM 15 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0791 per EA under NDC 53746055601. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on May 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746055601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA203482FDA Approved
5/23/2016
TE Code
AB
On Market Since
2/19/2024
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 15 MG CAPSULE has been published 26 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0791 per EA |
|---|---|
| All-time high | $0.0793 (Aug 12, 2026) |
| All-time low | $0.0779 (Feb 25, 2026) |
| 52-week high | $0.0793 |
| 52-week low | $0.0779 |
| Median price | $0.0791 |
| Average price | $0.0789 |
| Largest weekly change | +1.4% (Mar 18, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 15 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0791 per EA (NDC 53746055601), effective Aug 19, 2026.
How has the price of TEMAZEPAM 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 15 MG CAPSULE?
Since Feb 25, 2026, the NADAC for TEMAZEPAM 15 MG CAPSULE has ranged from a low of $0.0779 (Feb 25, 2026) to a high of $0.0793 (Aug 12, 2026), with a median of $0.0791 per EA.
Are there cheaper alternatives to TEMAZEPAM 15 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 15 MG CAPSULE?
TEMAZEPAM 15 MG CAPSULE (NDC 53746055601) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.